Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.
(Studio: Tom Brokaw) Report introduced.
(New York: Robert Bazell) The reaction to new revolutionary experimental cancer drugs examined; details given of the testing on mice and of the Wall Street reaction to EntreMed stock. [Memorial Sloan Kettering Dr. Joseph BERTINO - talks about this cancer therapy.] [Cancer patient Wendy HARPER - hopes for a cure.] [EntreMed's John HOLADAY, National Cancer Institute Dr. James PLUDA - comment on this treatment option.]
(Studio: Tom Brokaw) The view of M.D. Anderson Cancer Center Dr. Leonard Zwelling on the cancer drugs presented in his own words. [ZWELLING - offers a perspective on mouse model experiments, the need for human testing and how soon the drugs could be made available.]
- Bazell, Robert;
- Brokaw, Tom
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.